Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FL1HZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $55,035
Award facts
- Contract value 100% obligated
- $55,035.17 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $55,035.17 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors on January 29, 2026, with completion scheduled for January 30, 2026. This firm fixed-price delivery order was issued without a set-aside designation, indicating competitive award. The contract represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 through December 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania.
Dupixent is a specialty biologic medication used for treating conditions such as moderate-to-severe atopic dermatitis, asthma, and eosinophilic conditions. This procurement aligns with DLA's role in supplying critical pharmaceutical commodities to the Defense Health Agency, military treatment facilities, and other federal healthcare systems. As a major pharmaceutical distributor, AmerisourceBergen (operating under parent company Cencora) has established itself as a key federal vendor through multiple contract vehicles and demonstrates capability to fulfill government requirements for brand-name specialty medications across various therapeutic domains through open competition.
Quick answers
Who was awarded contract SPE2DR26FL1HZ?
SPE2DR26FL1HZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FL1HZ worth?
The government has obligated $55,035 on SPE2DR26FL1HZ.
Is contract SPE2DR26FL1HZ an order under another contract?
Yes. SPE2DR26FL1HZ is a delivery order under SPE2DR25D3401, an indefinite delivery contract.
Was contract SPE2DR26FL1HZ competed?
The extent of competition for SPE2DR26FL1HZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award